[{"id":"3dc175dd-15ff-4780-b0fb-4a99ac8eddd9","acronym":"","url":"https://clinicaltrials.gov/study/NCT05192460","created_at":"2022-01-14T13:53:58.745Z","updated_at":"2024-07-02T16:35:53.951Z","phase":"","brief_title":"Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer","source_id_and_acronym":"NCT05192460","lead_sponsor":"jianming xu","biomarkers":" IL6 • CD4 • IL2 • IL10","pipe":"","alterations":" ","tags":["IL6 • CD4 • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NEO_PLIN2101"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 03/28/2022","start_date":" 03/28/2022","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2023-03-07"}]